OptiChroniX is a Swiss Digital Therapeutics company dedicated to improving brain health early.
We strive to optimize lifestyle and make medicine smart, so as to improve clinical outcomes, quality of life, cost-effectiveness and budget impact of clinical treatment.
At OptiChroniX, we develop digital health interventions at the intersection of biomedical, behavioural, computing and engineering research, deployed on smartphones to personalize and track a patients health progress by collecting data from other wearables and nearables.
The informed choices offered aim to provide tailored coaching in order to improve health literacy and medication adherence, and to positively impact modifiable risk factors primarily responsible for the cognitive decline in patients affected by dementia
07.08.2024
Entering a new phase with experienced industry experts (startupticker.ch)
23.12.2020
09.02.2020
InnoCheck
15.03.2019
Strategic Partnership Sprout Behavioral Science
No Jobs
Imagine People Affected with Dementia
The venture business plan competition takes place every year and combines a competition, learning events and contact form in one. It is an initiative of the ETH Zurich, CTI and McKinsey.
Website:
www.optichronix.com
Headquarter:
Schoenenbuch
Foundation Date:
May 2020
Technology:
Sectors: